Two veterans who had previously undergone sleeve gastrectomies but failed to achieve sufficient weight loss and diabetes control were recently treated with Vbloc Neurometabolic Therapy, representing the first time the device has been used as an adjunctive treatment to a previous gastric surgery.

Medtronic plc.'s $49.9 billion Covidien acquisition, which closed in January 2017, boosted the company's fiscal year 2016 revenue 42 percent (or 7 percent on a constant currency basis, which includes a first quarter extra week benefit) to a record $28.8333 billion. Fourth quarter revenue grew 4 percent (6 percent at constant currency) to $7.6 billion, beating analysts' expectations for 3 percent growth.